Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C3H8N2OS |
| Molecular Weight | 120.173 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC(=S)NCO
InChI
InChIKey=JLMHZVYLAQPMOZ-UHFFFAOYSA-N
InChI=1S/C3H8N2OS/c1-4-3(7)5-2-6/h6H,2H2,1H3,(H2,4,5,7)
| Molecular Formula | C3H8N2OS |
| Molecular Weight | 120.173 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/3142635Curator's Comment: Description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/3142634 | http://www.ncbi.nlm.nih.gov/pubmed/3097078 |
http://www.ncbi.nlm.nih.gov/pubmed/35068 |
http://www.ncbi.nlm.nih.gov/pubmed/5835451
Sources: http://www.ncbi.nlm.nih.gov/pubmed/3142635
Curator's Comment: Description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/3142634 | http://www.ncbi.nlm.nih.gov/pubmed/3097078 |
http://www.ncbi.nlm.nih.gov/pubmed/35068 |
http://www.ncbi.nlm.nih.gov/pubmed/5835451
Noxythiolin is an antimicrobial agent. It can be used for irrigation procedures with noxythiolin solution to reduce the risk of sepsis in patients undergoing percutaneous drainage procedures. It seems mechanism of action is based on ability of noxythiolin to decompose in solution to liberate most of its formaldehyde.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0006590 Sources: http://www.ncbi.nlm.nih.gov/pubmed/2060892 |
9.0 µM [IC50] | ||
Target ID: map05130 Sources: http://www.ncbi.nlm.nih.gov/pubmed/2904994 |
|||
Target ID: map05150 Sources: http://www.ncbi.nlm.nih.gov/pubmed/2904994 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: http://www.ncbi.nlm.nih.gov/pubmed/6795589 |
Preventing | Unknown Approved UseUnknown |
||
| Preventing | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Activity of disinfectants against Gram-negative bacilli isolated from patients undergoing lung transplantation for cystic fibrosis. | 2002-11 |
|
| Comparative studies on the effect of noxythiolin and other thioureas on the thyroid using in vitro and in vivo models of thyroid function. | 1991-05 |
|
| The activity of locally applied cytotoxics to breast cancer cells in vitro. | 1991-03 |
|
| In-vitro antibacterial activity of noxythiolin and taurolidine. | 1990-08 |
|
| [Adjuvant treatment of tubal surgery. Randomized prospective study of systemically administered corticoids and noxythiolin]. | 1989 |
|
| Sustained anti-adherence activity of taurolidine (Taurolin) and noxythiolin (Noxyflex S) solutions. | 1988-07 |
|
| Determination of in vivo concentration-time profiles of chlorhexidine and noxythiolin bladder irrigations. | 1986-10 |
|
| Inhibition of hyphal development and kill of Candida albicans blastospores by noxythiolin in vitro. | 1986-04 |
|
| An investigation of the in vitro anti-bacterial activity of noxythiolin against 1,000 pathogenic bacterial isolates. | 1986-04 |
|
| A comparison of noxythiolin and povidone-iodine in experimentally induced peritoneal infection in mice. | 1978-09 |
|
| Release of formaldehyde from polynoxylin and noxythiolin. | 1965-09 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/2060892
Noxythiolin (Noxyflex-S) inhibited iodide organification (thyroid hormone synthesis) by cultured porcine thyrocytes in vitro after 5 hr (IC50 approx. 9.0 microM)
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:33:21 GMT 2025
by
admin
on
Wed Apr 02 08:33:21 GMT 2025
|
| Record UNII |
4DN3AF1FU6
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
B05CA07
Created by
admin on Wed Apr 02 08:33:21 GMT 2025 , Edited by admin on Wed Apr 02 08:33:21 GMT 2025
|
||
|
WHO-VATC |
QB05CA07
Created by
admin on Wed Apr 02 08:33:21 GMT 2025 , Edited by admin on Wed Apr 02 08:33:21 GMT 2025
|
||
|
NCI_THESAURUS |
C28394
Created by
admin on Wed Apr 02 08:33:21 GMT 2025 , Edited by admin on Wed Apr 02 08:33:21 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m8083
Created by
admin on Wed Apr 02 08:33:21 GMT 2025 , Edited by admin on Wed Apr 02 08:33:21 GMT 2025
|
PRIMARY | Merck Index | ||
|
239-679-5
Created by
admin on Wed Apr 02 08:33:21 GMT 2025 , Edited by admin on Wed Apr 02 08:33:21 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106441
Created by
admin on Wed Apr 02 08:33:21 GMT 2025 , Edited by admin on Wed Apr 02 08:33:21 GMT 2025
|
PRIMARY | |||
|
C66248
Created by
admin on Wed Apr 02 08:33:21 GMT 2025 , Edited by admin on Wed Apr 02 08:33:21 GMT 2025
|
PRIMARY | |||
|
SUB09387MIG
Created by
admin on Wed Apr 02 08:33:21 GMT 2025 , Edited by admin on Wed Apr 02 08:33:21 GMT 2025
|
PRIMARY | |||
|
1234
Created by
admin on Wed Apr 02 08:33:21 GMT 2025 , Edited by admin on Wed Apr 02 08:33:21 GMT 2025
|
PRIMARY | |||
|
DB13838
Created by
admin on Wed Apr 02 08:33:21 GMT 2025 , Edited by admin on Wed Apr 02 08:33:21 GMT 2025
|
PRIMARY | |||
|
4DN3AF1FU6
Created by
admin on Wed Apr 02 08:33:21 GMT 2025 , Edited by admin on Wed Apr 02 08:33:21 GMT 2025
|
PRIMARY | |||
|
D009677
Created by
admin on Wed Apr 02 08:33:21 GMT 2025 , Edited by admin on Wed Apr 02 08:33:21 GMT 2025
|
PRIMARY | |||
|
NOXYTIOLIN
Created by
admin on Wed Apr 02 08:33:21 GMT 2025 , Edited by admin on Wed Apr 02 08:33:21 GMT 2025
|
PRIMARY | |||
|
5251503
Created by
admin on Wed Apr 02 08:33:21 GMT 2025 , Edited by admin on Wed Apr 02 08:33:21 GMT 2025
|
PRIMARY | |||
|
DTXSID20166011
Created by
admin on Wed Apr 02 08:33:21 GMT 2025 , Edited by admin on Wed Apr 02 08:33:21 GMT 2025
|
PRIMARY | |||
|
15599-39-0
Created by
admin on Wed Apr 02 08:33:21 GMT 2025 , Edited by admin on Wed Apr 02 08:33:21 GMT 2025
|
PRIMARY | |||
|
3391
Created by
admin on Wed Apr 02 08:33:21 GMT 2025 , Edited by admin on Wed Apr 02 08:33:21 GMT 2025
|
PRIMARY | |||
|
7543
Created by
admin on Wed Apr 02 08:33:21 GMT 2025 , Edited by admin on Wed Apr 02 08:33:21 GMT 2025
|
PRIMARY | RxNorm | ||
|
100000083606
Created by
admin on Wed Apr 02 08:33:21 GMT 2025 , Edited by admin on Wed Apr 02 08:33:21 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |